Education
About Us
Working with TipRanks
Follow Us
Granfield Christine Insider Profile
4 Followers
Granfield Christine, VP, Head of Reg Affairs/Qual at Leap Therapeutics, holds ― shares in Leap Therapeutics (Ticker: LPTX). Most recently, Granfield Christine ― shares of Leap Therapeutics on ― for an estimated value of ―.
Granfield Christine has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Granfield Christine does not currently own shares as a corporate insider.
A breakdown of Granfield Christine's holdings
Insider Roles
VP, Head of Reg Affairs/Qual
Roles that Granfield Christine holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Granfield Christine
Granfield Christine's Trading History
List of latest transactions for each holding click on a transaction to see Granfield Christine's performance on stock
You May Also Like
Granfield Christine insider profile FAQ
What is the percentage of profitable transactions made by Granfield Christine?
The percentage of profitable transactions made by Granfield Christine is ―.
What is the average return per transaction made by Granfield Christine?
The average return per transaction made by Granfield Christine is ―.
What stocks does Granfield Christine hold?
Granfield Christine holds: LPTX stocks.
What was Granfield Christine’s latest transaction?
Granfield Christine latest transaction was an Uninformative Buy of ―.
What was Granfield Christine's most profitable transaction?
Granfield Christine’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Granfield Christine's role in Leap Therapeutics?
Granfield Christine's role in Leap Therapeutics is VP, Head of Reg Affairs/Qual.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.